Lipid composition, pharmaceutical composition comprising same, and uses thereof
Patent Information
- Application Number
- CN202511629212.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-11-08
- Filing Date
- 2025-11-07
- Publication Date
- 2026-03-03
AI Technical Summary
Existing lipid nanoparticle (LNP) delivery systems primarily target the liver, making it difficult to effectively target other organs, especially the lungs, thus impacting the treatment and prevention of lung diseases.
By adjusting the component structure and ratio of lipid compositions, especially by using a specific molar ratio of cationic lipids, steroidal lipids, and polyethylene glycol-modified lipids, a lung-targeting lipid composition was developed to carry the active pharmaceutical ingredient into the lungs.
This approach enables targeted delivery and accumulation of drugs in the lungs, improves nucleic acid expression and cell transfection efficiency in target organs, and provides a new approach to precision biological therapy for lung diseases.
Smart Images

Figure CN121588232A_ABST
Abstract
Citation Information
Patent Citations
Cationic lipid compound, preparation method thereof, composition containing cationic lipid compound and application
CN117964577A